| Product Code: ETC10075646 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Heart Failure Diagnostics/Therapeutics Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam Heart Failure Diagnostics/Therapeutics Market - Industry Life Cycle |
3.4 Vietnam Heart Failure Diagnostics/Therapeutics Market - Porter's Five Forces |
3.5 Vietnam Heart Failure Diagnostics/Therapeutics Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
3.6 Vietnam Heart Failure Diagnostics/Therapeutics Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Vietnam Heart Failure Diagnostics/Therapeutics Market Revenues & Volume Share, By Tests, 2021 & 2031F |
4 Vietnam Heart Failure Diagnostics/Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of heart failure in Vietnam |
4.2.2 Growing awareness about the importance of early diagnosis and treatment |
4.2.3 Technological advancements in diagnostics and therapeutics for heart failure |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in rural areas |
4.3.2 High cost associated with diagnostics and therapeutics for heart failure |
4.3.3 Lack of skilled healthcare professionals specializing in heart failure management |
5 Vietnam Heart Failure Diagnostics/Therapeutics Market Trends |
6 Vietnam Heart Failure Diagnostics/Therapeutics Market, By Types |
6.1 Vietnam Heart Failure Diagnostics/Therapeutics Market, By Therapy |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Therapy, 2021- 2031F |
6.1.3 Vietnam Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Cardiac Resynchronization Therapy, 2021- 2031F |
6.1.4 Vietnam Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Ventricular Assist Devices, 2021- 2031F |
6.1.5 Vietnam Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Counterpulsation Implants, 2021- 2031F |
6.1.6 Vietnam Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Heart Failure Surgery, 2021- 2031F |
6.1.7 Vietnam Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Fluid Reduction (Renal Impairment), 2021- 2031F |
6.1.8 Vietnam Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Neurostimulation, 2021- 2031F |
6.1.9 Vietnam Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Central Sleep Apnea, 2021- 2031F |
6.1.10 Vietnam Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Central Sleep Apnea, 2021- 2031F |
6.2 Vietnam Heart Failure Diagnostics/Therapeutics Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By ECG Systems, 2021- 2031F |
6.2.3 Vietnam Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Holter Monitors, 2021- 2031F |
6.2.4 Vietnam Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Event Monitors, 2021- 2031F |
6.2.5 Vietnam Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Implantable Loop Recorders, 2021- 2031F |
6.3 Vietnam Heart Failure Diagnostics/Therapeutics Market, By Tests |
6.3.1 Overview and Analysis |
6.3.2 Vietnam Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Blood Tests, 2021- 2031F |
6.3.3 Vietnam Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Chest X Ray, 2021- 2031F |
6.3.4 Vietnam Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Electrocardiogram, 2021- 2031F |
6.3.5 Vietnam Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Echocardiogram, 2021- 2031F |
6.3.6 Vietnam Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Stress Test, 2021- 2031F |
6.3.7 Vietnam Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Cardiac Computerized Tomography (CT) Scan or Magnetic Resonance Imaging, 2021- 2031F |
6.3.8 Vietnam Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Myocardial Biopsy, 2021- 2031F |
6.3.9 Vietnam Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Myocardial Biopsy, 2021- 2031F |
7 Vietnam Heart Failure Diagnostics/Therapeutics Market Import-Export Trade Statistics |
7.1 Vietnam Heart Failure Diagnostics/Therapeutics Market Export to Major Countries |
7.2 Vietnam Heart Failure Diagnostics/Therapeutics Market Imports from Major Countries |
8 Vietnam Heart Failure Diagnostics/Therapeutics Market Key Performance Indicators |
8.1 Average age of diagnosis of heart failure patients in Vietnam |
8.2 Percentage of population undergoing regular heart health screenings |
8.3 Adoption rate of new technologies in heart failure diagnostics and therapeutics |
9 Vietnam Heart Failure Diagnostics/Therapeutics Market - Opportunity Assessment |
9.1 Vietnam Heart Failure Diagnostics/Therapeutics Market Opportunity Assessment, By Therapy, 2021 & 2031F |
9.2 Vietnam Heart Failure Diagnostics/Therapeutics Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 Vietnam Heart Failure Diagnostics/Therapeutics Market Opportunity Assessment, By Tests, 2021 & 2031F |
10 Vietnam Heart Failure Diagnostics/Therapeutics Market - Competitive Landscape |
10.1 Vietnam Heart Failure Diagnostics/Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Vietnam Heart Failure Diagnostics/Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here